WO2005094210A3 - Multi-action anthelmintic formulations - Google Patents
Multi-action anthelmintic formulations Download PDFInfo
- Publication number
- WO2005094210A3 WO2005094210A3 PCT/US2004/025001 US2004025001W WO2005094210A3 WO 2005094210 A3 WO2005094210 A3 WO 2005094210A3 US 2004025001 W US2004025001 W US 2004025001W WO 2005094210 A3 WO2005094210 A3 WO 2005094210A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical formulation
- action
- mammals
- provides
- helminthiasis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55268204P | 2004-03-12 | 2004-03-12 | |
US60/552,682 | 2004-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005094210A2 WO2005094210A2 (en) | 2005-10-13 |
WO2005094210A3 true WO2005094210A3 (en) | 2006-03-30 |
Family
ID=35064207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/025001 WO2005094210A2 (en) | 2004-03-12 | 2004-08-03 | Multi-action anthelmintic formulations |
Country Status (2)
Country | Link |
---|---|
US (1) | US7582612B2 (en) |
WO (1) | WO2005094210A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100024075A1 (en) * | 2005-11-23 | 2010-01-28 | Aroian Raffi V | Method for Controlling Plant-Parasitic Nematode Infections in Plants |
US7955632B2 (en) | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
US20070128251A1 (en) | 2005-12-07 | 2007-06-07 | Piedmont Pharmaceuticals, Inc. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
NZ552290A (en) * | 2006-12-21 | 2009-05-31 | Bomac Research Ltd | Tablet fomulation |
AU2008360070B2 (en) * | 2008-07-29 | 2015-04-30 | Bomac Research Limited | Tablet manufacturing method |
US8809268B2 (en) | 2008-10-29 | 2014-08-19 | The Regents Of The University Of California | Combination therapy to combat helminth resistance |
TW201041510A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
TW201041507A (en) | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity and methods for preparing same |
TW201041508A (en) * | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
TW201041509A (en) | 2009-04-30 | 2010-12-01 | Dow Agrosciences Llc | Pesticide compositions exhibiting enhanced activity |
GB2475701B (en) * | 2009-11-26 | 2011-10-19 | Michael Hilary Burke | A process for the preparation of an orally administered anthelmintic unit dose tablet |
CN104586803B (en) * | 2015-02-12 | 2019-11-22 | 浙江华海药业股份有限公司 | A kind of preparation method of the net microcrystalline cellulose compositions of En Gelie |
WO2019005700A1 (en) | 2017-06-26 | 2019-01-03 | Merial, Inc. | Dual active parasiticidal granule compositions, methods and uses thereof |
CN108489196B (en) * | 2018-03-30 | 2019-03-05 | 内蒙古拜克生物有限公司 | A kind of avermectin crystal drying means |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
US20010044464A1 (en) * | 1998-10-19 | 2001-11-22 | Agro-Kanesho Co., Ltd. | Hydrazine oxoacetamide derivative and insecticide |
US6492340B2 (en) * | 2000-02-16 | 2002-12-10 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793358A (en) * | 1971-12-27 | 1973-06-27 | Hoechst Ag | NEW 2-CARBALCOXY-AMINO-BENZIMIDAZOLE DERIVATIVES PRESENTING ANTHELMINTIC ACTIVITY AND THEIR PREPARATION PROCESS |
IN142490B (en) * | 1974-05-15 | 1977-07-16 | Bayer Ag | |
DE2841668A1 (en) * | 1978-09-25 | 1980-04-10 | Bayer Ag | MEDICATED ANIMAL FEED BASED ON LIVER FLOUR |
JPS57139012A (en) | 1981-02-23 | 1982-08-27 | Sankyo Co Ltd | Anthelmintic composition |
US4447414A (en) * | 1982-12-21 | 1984-05-08 | Cutter Laboratories, Inc. | Carnivore anthelmintics |
US4717566A (en) * | 1984-03-19 | 1988-01-05 | Alza Corporation | Dosage system and method of using same |
DE3411627A1 (en) * | 1984-03-29 | 1985-10-03 | Bayer Ag, 5090 Leverkusen | STABILIZED ANTHELMINTIC FORMULATIONS |
DE3634755A1 (en) * | 1986-10-11 | 1988-04-14 | Bayer Ag | DERMAL TREATMENT OF CAT WORM DISEASES WITH PRAZIQUANTEL |
DE3705227A1 (en) * | 1987-02-19 | 1988-09-01 | Bayer Ag | ANTHELMINTHIC ACTIVE COMBINATIONS |
DE3921399A1 (en) * | 1989-06-29 | 1991-01-10 | Gruenzweig & Hartmann | METHOD AND DEVICE FOR THE PRODUCTION OF MINERAL WOOL FABRICS FROM PARTICULAR STONE WOOL |
GB9024924D0 (en) * | 1990-11-16 | 1991-01-02 | Beecham Group Plc | Novel compositions |
NZ247278A (en) | 1991-02-12 | 1995-03-28 | Ancare Distributors | Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier |
DE4208254A1 (en) * | 1992-03-14 | 1993-09-16 | Hoechst Ag | SUBSTITUTED PYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL AND FUNGICIDE |
BR9406627A (en) * | 1993-05-26 | 1996-02-06 | Commw Scient Ind Res Org | Antiparasitic compositions |
US5538989A (en) * | 1993-11-10 | 1996-07-23 | Hoechst-Roussel Agri-Vet Company | Fenbendazole formulations |
US5550153A (en) * | 1994-11-14 | 1996-08-27 | Kerz; Phillip D. | Method for treating heartworm-infected canines |
AUPM969994A0 (en) | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
PT810823E (en) * | 1995-02-24 | 2001-09-28 | Novartis Ag | COMPOSITION FOR CONTROL OF PARASITES |
US5861142A (en) * | 1996-03-25 | 1999-01-19 | Schick; Mary Pichler | Method for promoting hair, nail, and skin keratinization |
AUPN933396A0 (en) * | 1996-04-17 | 1996-05-09 | Pfizer Pty Limited | Non-aqueuos oral-drench compositions containing avermectin compounds |
US6214367B1 (en) * | 1996-06-05 | 2001-04-10 | Ashmont Holdings Limited | Injectable compositions |
DE19628776A1 (en) * | 1996-07-17 | 1998-01-22 | Bayer Ag | Oral granules of hexahydropyrazine derivatives |
US5834260A (en) * | 1996-08-30 | 1998-11-10 | Merck & Co., Inc. | Antiparasitic agents |
DE19638045A1 (en) | 1996-09-18 | 1998-03-19 | Bayer Ag | Injection formulations of avermectins and milbemycins |
DE19654079A1 (en) * | 1996-12-23 | 1998-06-25 | Bayer Ag | Endo-ecto-parasiticidal agents |
ZA9711534B (en) | 1996-12-24 | 1998-06-24 | Rhone Poulenc Agrochimie | Pesticidal 1-arylpyrazoles. |
DE19725450A1 (en) * | 1997-06-16 | 1998-12-17 | Hoechst Schering Agrevo Gmbh | 4-Haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions containing them and their use as pesticides |
US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
DE69833000T2 (en) * | 1997-09-26 | 2006-09-07 | Noven Pharmaceuticals, Inc., Miami | BIO-ADHESIVE COMPOSITIONS |
US6524602B1 (en) | 1998-10-13 | 2003-02-25 | Craig G. Burkhart | Polymer delivery system in treatments for parasitic skin diseases |
CO5210925A1 (en) * | 1998-11-17 | 2002-10-30 | Novartis Ag | TETRASUSTITUID DIAMINUM NITROGUANIDINE DERIVATIVES |
US6265384B1 (en) | 1999-01-26 | 2001-07-24 | Dale L. Pearlman | Methods and kits for removing, treating, or preventing lice with driable pediculostatic agents |
US6605595B1 (en) * | 1999-02-09 | 2003-08-12 | The Kitasato Institute | Avermectin derivatives |
CH693625A5 (en) | 1999-02-18 | 2003-11-28 | Inpharma Sa | Pharmaceutical compositions containing compounds of promoter activity of absorption of active ingredients. |
US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
AU781682B2 (en) * | 2000-03-20 | 2005-06-09 | Zoetis Services Llc | Sustained-release compositions for parenteral administration |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
DE10031044A1 (en) * | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasiticidal agents for voluntary oral ingestion by animals |
US6524455B1 (en) * | 2000-10-04 | 2003-02-25 | Eni Technology, Inc. | Sputtering apparatus using passive arc control system and method |
US20030064941A1 (en) | 2001-05-21 | 2003-04-03 | Pfizer Inc. | Avermectin and praziquantel combination therapy |
US6627613B2 (en) * | 2001-07-23 | 2003-09-30 | Michael A. Strobel | Application of water and organic solvent soluble ivermectin for topical and oral use |
US6872708B2 (en) * | 2001-09-10 | 2005-03-29 | Mitsukazu Matsumoto | Local injection prescription |
DE10146873A1 (en) * | 2001-09-24 | 2003-04-17 | Bayer Cropscience Gmbh | Heterocyclic amides and imine derivatives, processes for their preparation, compositions containing them and their use as pesticides |
DE10148290A1 (en) * | 2001-09-29 | 2003-04-17 | Bayer Cropscience Gmbh | Heterocyclic amides, processes for their preparation, compositions containing them and their use |
US20040224012A1 (en) * | 2001-10-05 | 2004-11-11 | Pichit Suvanprakorn | Topical application and methods for administration of active agents using liposome macro-beads |
AU2002337815A1 (en) | 2001-10-05 | 2003-04-22 | Suwalee Chandrkrachang | Active agents using liposome beads |
ES2439725T3 (en) * | 2001-10-05 | 2014-01-24 | Rubicon Scientific Llc | Feed for animals that include active ingredients |
US6887900B2 (en) * | 2002-03-04 | 2005-05-03 | Divergence, Inc. | Nematicidal compositions and methods |
US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
DE10228680A1 (en) * | 2002-06-27 | 2004-01-22 | Holden Development Limited, Tortola | Basis for transdermal formulations (PTF) |
US6764999B2 (en) * | 2002-07-11 | 2004-07-20 | Stephen E. Bachman | Nasal delivery of parasiticides |
AU2003267999B2 (en) * | 2002-07-19 | 2010-03-11 | Abbvie Biotechnology Ltd | Treatment of TNFalpha related disorders |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
US20040180034A1 (en) * | 2003-03-10 | 2004-09-16 | Lyn Hughes | Anthelmintic resinates and a method for their preparation |
US20040234579A1 (en) * | 2003-05-22 | 2004-11-25 | Mark D. Finke, Inc. | Dietary supplements and methods of preparing and administering dietary supplements |
US7396819B2 (en) * | 2003-08-08 | 2008-07-08 | Virbac Corporation | Anthelmintic formulations |
US7671034B2 (en) * | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
-
2004
- 2004-08-03 US US10/910,504 patent/US7582612B2/en active Active
- 2004-08-03 WO PCT/US2004/025001 patent/WO2005094210A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
US20010044464A1 (en) * | 1998-10-19 | 2001-11-22 | Agro-Kanesho Co., Ltd. | Hydrazine oxoacetamide derivative and insecticide |
US6492340B2 (en) * | 2000-02-16 | 2002-12-10 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
Non-Patent Citations (1)
Title |
---|
HARDER A. ET AL: "Cyclooctadepsipeptides-an anthelmintically active class of compounds exhibiting a novel mode of action", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 22, no. 3, September 2003 (2003-09-01), pages 318 - 331, XP002995541 * |
Also Published As
Publication number | Publication date |
---|---|
US20050203034A1 (en) | 2005-09-15 |
WO2005094210A2 (en) | 2005-10-13 |
US7582612B2 (en) | 2009-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005094210A3 (en) | Multi-action anthelmintic formulations | |
JO3147B1 (en) | Substituted 2,3-dihydroimidazo[ 1,2- c] quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders And Diseases Associated with Angiogenesis | |
WO2008092006A3 (en) | Antimicrobial compositions | |
WO2006055352A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally | |
MY147393A (en) | Administration of dipeptidyl peptidase inhibitors | |
BR0312573A (en) | Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives | |
WO2006010589A3 (en) | Post foaming gel mousse | |
TW200615266A (en) | Organic compounds | |
BRPI0513811A (en) | imidazo [4,5-d] pyrimidines, their uses and processes of preparation | |
NO20054208L (en) | Nitrogen-substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, methods of preparation and use thereof as medicaments | |
NO20084703L (en) | Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases | |
WO2007087068A3 (en) | Inhibitors of tyrosine kinases and uses thereof | |
TNSN07341A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
BRPI0508579A (en) | compound, pharmaceutical composition, and use of a compound | |
WO2005094554A3 (en) | Therapeutic agents, methods, and treatments | |
MX2010002392A (en) | Improved brimonidine compositions for treating erythema. | |
NO20055766L (en) | Positive modulators of nicotine acetylcholine receptors | |
BRPI0415953B8 (en) | controlled release dosage formulation and set of controlled release dosage forms | |
NO20064811L (en) | 4- (5-Aminomethyl-2-fluoro-phenyl) -piperidin-1-yl] - (4-bromo-3-methyl-5-propoxy-thiophen-2-yl) -methanone hydrochloride as an inhibitor of mast cell tryptase | |
WO2006116733A3 (en) | Protein kinase inhibitors | |
WO2009091550A3 (en) | Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis | |
WO2007012947A3 (en) | Method of treating ischemia-reperfusion injury | |
UY30158A1 (en) | USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT | |
WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
NO20051023L (en) | Oral administration of calcitonin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |